Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11801 - 11825 of 12697 in total
Rostafuroxin has been used in trials studying the treatment of Essential Hypertension.
Investigational
Matched Description: … Rostafuroxin has been used in trials studying the treatment of Essential Hypertension. …
Chlorine Dioxide has been used in trials studying the treatment of Halitosis.
Investigational
Matched Description: … Chlorine Dioxide has been used in trials studying the treatment of Halitosis. …
JNJ-37822681 has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Description: … JNJ-37822681 has been used in trials studying the treatment of Schizophrenia. …
Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.
Investigational
Matched Description: … Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia. …
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Azeliragon has been used in trials studying the treatment of Alzheimer's Disease. …
Monteplase has been used in trials studying the treatment of Pulmonary Embolism.
Investigational
Matched Description: … Monteplase has been used in trials studying the treatment of Pulmonary Embolism. …
Tiplimotide has been used in trials studying the treatment of Multiple Sclerosis.
Investigational
Matched Description: … Tiplimotide has been used in trials studying the treatment of Multiple Sclerosis. …
GW493838 has been used in trials studying the treatment of Neuropathic Pain.
Investigational
Matched Description: … GW493838 has been used in trials studying the treatment of Neuropathic Pain. …
Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Description: … Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer. …
p-Quaterphenyl has been used in trials studying the treatment of Malaria.
Investigational
Matched Description: … p-Quaterphenyl has been used in trials studying the treatment of Malaria. …
Clazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Clazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
Raluridine has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Raluridine has been used in trials studying the treatment of HIV Infections. …
Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma.
Investigational
Matched Description: … Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma. …
Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of darolutamide.
Experimental
Matched Description: … Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of [darolutamide …
GSBR-1290 is a small molecule agonist of the GLP-1 receptor.
Investigational
Matched Description: … GSBR-1290 is a small molecule agonist of the GLP-1 receptor. …
Ferric pyrophosphate is an iron replacement product. Free iron presents several side effects as it can catalyze free radical formation and lipid peroxidation as well as the presence of interactions of iron in plasma. The ferric ion is strongly complexed by pyrophosphate. It presents an increasing interest as this insoluble...
Experimental
Matched Description: … interactions of iron in plasma. ... side effects as it can catalyze free radical formation and lipid peroxidation as well as the presence of
Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine. Putrescine is a solid. This compound belongs to the polyamines. These are compounds containing more than one amine group. Known drug targets of putrescine include putrescine-binding periplasmic protein, ornithine decarboxylase, and S-adenosylmethionine decarboxylase proenzyme.
Experimental
Matched Description: … Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine ... Known drug targets of putrescine include putrescine-binding periplasmic protein, ornithine decarboxylase …
MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.
Investigational
Matched Description: … MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis ... regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of
Quaternium-18 is a mixture of quaternary ammonium chloride salts. Quaternium-18 Hectorite and Bentonite are the reaction products of Quaternium-18 with clays. These compounds are poorly absorbed through the skin. Acute oral and percutaneous toxicity tests in animals indicate that they exhibit little or no systemic toxic effects.
Experimental
Matched Description: … Quaternium-18 is a mixture of quaternary ammonium chloride salts. ... Quaternium-18 Hectorite and Bentonite are the reaction products of Quaternium-18 with clays. …
Alfaxalone, also known as alphaxalone or alphaxolone, is a neuroactive steroid and general anaesthetic. It is used in veterinary practice under the trade name Alfaxan, and is licensed for use in both dogs and cats. Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin.
Vet approved
Matched Description: … Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin. …
Phosphorus P-32 is a radioactive isotope of phosphorus with beta particle-emitting radiocytotoxic activity. Emitted by phosphorus P32, beta particles directly damage cellular DNA and, by ionizing intracellular water to produce several types of cytotoxic free radicals and superoxides, indirectly damage intracellular biological macromolecules, resulting in tumor cell death.
Experimental
Matched Description: … Phosphorus P-32 is a radioactive isotope of phosphorus with beta particle-emitting radiocytotoxic activity ... particles directly damage cellular DNA and, by ionizing intracellular water to produce several types of
Avasopasem manganese, also known as GC4419, is a highly-selective small molecule mimetic of superoxide dismutase (SOD) being investigated for the reduction of radiation-induced severe oral mucositis.[L27246, L27256] This drug has potential application for radiation-induced esophagitis and oral mucositis, in addition to being currently tested against COVID-19.
Investigational
Matched Description: … Avasopasem manganese, also known as GC4419, is a highly-selective small molecule mimetic of superoxide ... dismutase (SOD) being investigated for the reduction of radiation-induced severe oral mucositis. …
NOX-700, an new orally active dithiocarbamate-based nitric oxide (NO) blocking agent that is in development for the treatment of diabetes mellitus (type 2 diabetes). In animal studies, NOX-700 lowered serum glucose, improved glucose tolerance, and reduced the percentage of total glycated hemoglobin. Immunohistochemical studies on pancreatic tissue also showed that...
Investigational
Matched Description: … active dithiocarbamate-based nitric oxide (NO) blocking agent that is in development for the treatment of ... animal studies, NOX-700 lowered serum glucose, improved glucose tolerance, and reduced the percentage of ... It has since been found that oxidative signaling of the redox-sensitive transcription factor, NF-κB, …
A novel anti-cancer compound synthesized by scientists at the University of California, San Diego more than a decade ago from toxins of the poisonous jack-o-lantern mushroom, has been granted “fast track” status by the U.S. Food and Drug Administration (FDA) after demonstrating promise against one of the most deadly cancers....
Investigational
Matched Description: … A novel anti-cancer compound synthesized by scientists at the University of California, San Diego more ... than a decade ago from toxins of the poisonous jack-o-lantern mushroom, has been granted “fast track ... Food and Drug Administration (FDA) after demonstrating promise against one of the most deadly cancers …
Eptacog alfa pegol (activated) has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With Inhibitors.
Investigational
Matched Description: … Eptacog alfa pegol (activated) has been used in trials studying the prevention and treatment of Haemophilia …
Displaying drugs 11801 - 11825 of 12697 in total